FC
TEVA icon

Forte Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Forte Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-6,634
Closed -$382K – 159
2014
Q4 		$382K Hold
6,634
– – 0.17% 120
2014
Q3 		$357K Buy
+6,634
New +$351K 0.16% 120

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Forte Capital's TEVA Position: Q1 2015 in Review

Forte Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2015, closing a stake of 6,634 shares — an estimated $382K sold.

Forte Capital first reported a position in TEVA in Q3 2014 and held it in 2 quarters. The position peaked at $382K in Q4 2014. 822 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.

  • Forte Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2015 after selling out during the quarter.
  • Forte Capital sold 6,634 Teva Pharmaceutical Industries Limited shares in Q1 2015, an estimated $382K.
  • Forte Capital first reported a position in Teva Pharmaceutical Industries Limited in Q3 2014 and held it in 2 quarters.
  • Forte Capital's Teva Pharmaceutical Industries Limited position peaked at $382K in Q4 2014.
  • 822 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2015.

Based on Forte Capital's 13F filing for Q1 2015, filed 13 Apr 2015.